ConductScience.org, home

Paper36765813

EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies.

Williams MV and 3 others. Cancers (Basel), 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies. Papers, record 36765813. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765813

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.84
iCite
Revised in PubMed
2026-10-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Williams MVMarshall V
2Mena-Palomo IIrene
3Cox BBrandonhttps://orcid.org/0000-0001-6753-6211
4Ariza MEMaria Eugeniahttps://orcid.org/0000-0003-2560-5367

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016058NCI NIH HHSUnited StatesP30CA016058PubMed and NIHNIH RePORTER
R01 AI084898NIAID NIH HHSUnited StatesR01AI084898PubMed and NIHNIH RePORTER
R01 AI084898NIH HHSUnited StatesR01AI084898PubMed and NIHNIH RePORTER

Download CSV of grants

References170

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122271878Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.Clin Cancer Res2012https://conductscience.org/library/papers/22271878PubMed
230021875Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells.mSphere2018https://conductscience.org/library/papers/30021875PubMed
323864627Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.J Virol2013https://conductscience.org/library/papers/23864627PubMed
425961061IL-21: a pleiotropic cytokine with potential applications in oncology.J Immunol Res2015https://conductscience.org/library/papers/25961061PubMed
535732829The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia2022https://conductscience.org/library/papers/35732829PubMed
633488588Epstein-Barr Virus and Systemic Autoimmune Diseases.Front Immunol2020https://conductscience.org/library/papers/33488588PubMed
733613459Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection.Front Microbiol2020https://conductscience.org/library/papers/33613459PubMed
831341086Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31341086PubMed
925790223To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis.PLoS Pathog2015https://conductscience.org/library/papers/25790223PubMed
1031856276EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.Blood2019https://conductscience.org/library/papers/31856276PubMed
1133228078Epstein-Barr Virus: How Its Lytic Phase Contributes to Oncogenesis.Microorganisms2020https://conductscience.org/library/papers/33228078PubMed
1215240677IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21.J Immunol2004https://conductscience.org/library/papers/15240677PubMed
1315728515Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma.J Immunol2005https://conductscience.org/library/papers/15728515PubMed
1431019051RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.J Virol2019https://conductscience.org/library/papers/31019051PubMed
1527405876Interleukin 21 - its potential role in the therapy of B-cell lymphomas.Leuk Lymphoma2017https://conductscience.org/library/papers/27405876PubMed
1624581222Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.Cancer Sci2014https://conductscience.org/library/papers/24581222PubMed
1735632758Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.Viruses2022https://conductscience.org/library/papers/35632758PubMed
1825367570T follicular helper cell differentiation, function, and roles in disease.Immunity2014https://conductscience.org/library/papers/25367570PubMed
1933661412Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma.Gastric Cancer2021https://conductscience.org/library/papers/33661412PubMed
2024896633Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells.PLoS One2014https://conductscience.org/library/papers/24896633PubMed

See all 170 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42098862EBV reactivation and immunoparalysis indicate a harmful immune endotype in sepsis.Crit Care2026https://conductscience.org/library/papers/42098862PubMed
41284185Epstein-Barr virus: biology, pathogenesis and therapy of lymphomas.Discov Oncol2025https://conductscience.org/library/papers/41284185PubMed
40740493HHV-6 and EBV reactivation in relapsing remitting multiple sclerosis: Disability, progression, and inflammation links.iScience2025https://conductscience.org/library/papers/40740493PubMed
39537445Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities.Curr Opin Virol2024https://conductscience.org/library/papers/39537445PubMed
39044822Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis.Front Immunol2024https://conductscience.org/library/papers/39044822PubMed
38916727Endogenous Retroviruses Unveiled: A Comprehensive Review of Inflammatory Signaling/Senescence-Related Pathways and Therapeutic Strategies.Aging Dis2024https://conductscience.org/library/papers/38916727PubMed

Download CSV of cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOBEC3B9582PubTator's text mininghttps://conductscience.org/library/genes/9582NCBI Gene
ARID1A8289PubTator's text mininghttps://conductscience.org/library/genes/8289NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
DUT1854PubTator's text mininghttps://conductscience.org/library/genes/1854NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
ICOS29851PubTator's text mininghttps://conductscience.org/library/genes/29851NCBI Gene
ICOSLG23308PubTator's text mininghttps://conductscience.org/library/genes/23308NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
IL2159067PubTator's text mininghttps://conductscience.org/library/genes/59067NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
JUNB3726PubTator's text mininghttps://conductscience.org/library/genes/3726NCBI Gene
LOC102723996102723996PubTator's text mininghttps://conductscience.org/library/genes/102723996NCBI Gene
MGA23269PubTator's text mininghttps://conductscience.org/library/genes/23269NCBI Gene
MIR155406947PubTator's text mininghttps://conductscience.org/library/genes/406947NCBI Gene

See all 31 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36765813

GET https://conductscience.org/api/papers/v1/36765813/references?page=2